论文部分内容阅读
作者对68例退行发育的(anaplastic)大细胞B细胞淋巴瘤作了生存期分析,其中CD30~+组18例,CD30~+/-组25例,CD30~-组25例作对照组。各组死于该病的分别为9例(50％)、9例(36％)和11例(44％);平均生存月数分别为9、20和13个月,存活例数和平均随访期分别为9、16、14例和45、43和47个月。CD30~+组与CD30~-组,CD30~+/~-组与CD30~-组和CD30~+与CD3~+/~-组,各组间比较生存期均无
The authors analyzed the survival of 68 patients with anaplastic large cell B cell lymphoma, including 18 cases of CD30 ~ + group, 25 cases of CD30 ~ +/- group and 25 cases of CD30 ~ - group as control group. Nine patients (50%), 9 patients (36%) and 11 patients (44%) died of the disease in each group. The mean survival months were 9, 20 and 13 months respectively. The number of patients surviving and the average follow-up The periods were 9, 16, 14 and 45, 43, and 47 months respectively. CD30 ~ + group and CD30 ~ - group, CD30 ~ + / ~ - group and CD30 ~ - group and CD30 ~ + and CD3 ~ + / ~ - group, the survival of all groups were no